Ablation of Arteries for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities
This study is to assess the safety and performance of the Neurotronic Infusion Catheter and ethanol denervation of renal and hepatic arteries for the treatment of patients with Type 2 Diabetes (T2DM), Hypertension and Obesity.
Age ≥ 21 and ≤ 65 years at time of enrollment. [+12]
T1DM or poorly controlled T2DM (defined as HbA1c > 9.0% or use insulin as medica... [+58]